Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CRLF2 overexpression
i
Other names:
CRLF2, Cytokine Receptor Like Factor 2, Thymic Stromal Lymphopoietin Protein Receptor, Cytokine Receptor-Like Factor 2, TSLP Receptor, IL-XR, TSLPR, CRL2, Thymic Stromal-Derived Lymphopoietin Receptor, Cytokine Receptor CRL2 Precusor, Cytokine Receptor-Like 2, CRLF2Y, ILXR
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
64109
Related biomarkers:
Mutation
Fusion
Others
‹
P2RY8-CRLF2 fusion (3)
IGH-CRLF2 fusion (1)
P2RY8-CRLF2 fusion (3)
IGH-CRLF2 fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
Sensitive: C3 – Early Trials
inotuzumab ozogamicin
Sensitive
:
C3
inotuzumab ozogamicin
Sensitive: C3 – Early Trials
inotuzumab ozogamicin
Sensitive
:
C3
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive: C3 – Early Trials
blinatumomab
Sensitive
:
C3
blinatumomab
Sensitive: C3 – Early Trials
blinatumomab
Sensitive
:
C3
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
CRLF2 overexpression
B Acute Lymphoblastic Leukemia
blinatumomab + inotuzumab ozogamicin
Sensitive: C3 – Early Trials
blinatumomab + inotuzumab ozogamicin
Sensitive
:
C3
blinatumomab + inotuzumab ozogamicin
Sensitive: C3 – Early Trials
blinatumomab + inotuzumab ozogamicin
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login